Patients with hemophilia have long relied on intravenous injections of concentrated blood clotting factors to help stop the bleeding episodes associated with the disease. Recently, a new drug which works differently than other hemophilia medications came to market. The drug offers the prospect of fewer injections and fewer bleeds for those taking it.
The accompanying video demonstrates how Optum Rx is helping to get these life-altering medicines into the hands of patients and the profound impact it has had on one patient and his family.
Related healthcare insights
White paper
Integrating specialty pharmacy means better care, lower costs.
Article
Achieve savings by targeting expensive, low-value drugs.
Article
Explore three principles driving better pharmacy benefit decisions.